Agios 制药 AGIO
$29.41 +$1.14 (+4.03%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $28.97 -1.50%
开盘$28.99
昨收$28.27
当日区间$28.46 – $29.80
成交量1.28M
市值$1.76B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$44.75M+259.3% YoY
营业利润-$110.55M+13.0% YoY
净利润-$100.70M+10.1% YoY
摊薄每股收益-$1.69+12.4% YoY
自由现金流-$83.52M+5.1% YoY
经营现金流-$57.31M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率92.0%
营业利润率-466.8%
净利率-418.2%
净资产收益率-34.3%
资产收益率-31.9%
投入资本回报率-37.0%
流动比率10.22
负债/资产比率7.4%
现金及投资$617.58M
总负债$11.95M
净现金（净负债）$605.63M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $44.75M | $20.75M | $54.03M | $19.97M | $12.88M |
| 营业总收入 | $44.75M | $20.75M | $54.03M | $19.97M | $12.88M |
| 营业成本 | $3.00M | $1.32M | $6.35M | $1.88M | $1.68M |
| 毛利润 | $41.75M | $19.43M | $47.68M | $18.09M | $11.20M |
| 营业费用 | $152.30M | $129.45M | $519.82M | $139.67M | $128.07M |
| 销售及管理费用 | $51.55M | $48.30M | $180.28M | $51.61M | $41.27M |
| 研发费用 | $100.75M | $81.15M | $339.54M | $88.06M | $86.80M |
| 营业利润 | -$110.55M | -$110.03M | -$472.13M | -$121.58M | -$116.87M |
| 非经营性利息净收入（支出） | $9.73M | $10.80M | $56.38M | $12.41M | $13.37M |
| 非经营性利息收入 | $9.73M | $10.80M | $56.38M | $12.41M | $13.37M |
| 其他收入（支出） | $119,000.00 | $119,000.00 | $1.96M | $113,000.00 | $67,000.00 |
| 其他非经营性收入（支出） | $119,000.00 | $119,000.00 | $1.96M | $113,000.00 | $67,000.00 |
| 税前利润 | -$100.70M | -$99.11M | -$413.80M | -$109.06M | -$103.43M |
| 净利润 | -$100.70M | -$99.11M | -$412.78M | -$108.04M | -$103.43M |
| 持续经营利润 | -$100.70M | -$99.11M | -$412.78M | -$108.04M | -$103.43M |
| 归属母公司净利润 | -$100.70M | -$99.11M | -$412.78M | -$108.04M | -$103.43M |
| 归属普通股股东净利润 | -$100.70M | -$99.11M | -$412.78M | -$108.04M | -$103.43M |
| 基本每股收益 | -$1.69 | -$1.69 | -$7.12 | -$1.85 | -$1.78 |
| 摊薄每股收益 | -$1.69 | -$1.69 | -$7.12 | -$1.85 | -$1.78 |
| 特殊收益（费用） | – | – | $0.00 | $0.00 | $0.00 |
| -业务出售收益 | – | – | $0.00 | $0.00 | $0.00 |
| 税费 | – | – | -$1.02M | -$1.02M | $0.00 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $1.11B | $1.18B | $1.30B | $1.30B | $1.39B |
| 流动资产合计 | $717.67M | $834.84M | $942.05M | $942.05M | $1.03B |
| 现金及现金等价物与短期投资 | $617.58M | $113.60M | $854.43M | $854.43M | $952.86M |
| -现金及现金等价物 | $99.65M | $113.60M | $89.13M | $89.13M | $92.71M |
| -短期投资 | $517.93M | – | $765.30M | $765.30M | $860.15M |
| 应收款 | $24.22M | – | $10.58M | $10.58M | $5.03M |
| -应收账款 | $20.11M | $16.13M | $10.58M | $10.58M | $5.03M |
| -其他应收款 | $4.10M | – | – | – | – |
| 存货 | $30.15M | $35.09M | $32.92M | $32.92M | $32.03M |
| 其他流动资产 | $45.72M | $799.76M | $44.13M | $44.13M | $43.19M |
| 非流动资产合计 | $390.76M | $350.15M | $355.17M | $355.17M | $352.60M |
| 固定资产净值 | $33.82M | – | $41.23M | $41.23M | $44.33M |
| -固定资产原值 | $33.82M | – | $101.34M | $101.34M | $44.33M |
| 投资及预付款 | $347.25M | – | $310.01M | $310.01M | $304.34M |
| -可供出售证券 | $347.25M | – | $310.01M | $310.01M | $304.34M |
| 其他非流动资产 | $9.68M | $350.15M | $3.93M | $3.93M | $3.93M |
| 负债合计 | $82.40M | $75.88M | $104.11M | $104.11M | $101.38M |
| 流动负债合计 | $70.22M | $58.85M | $82.21M | $82.21M | $74.76M |
| 应付款 | $16.35M | – | $18.36M | $18.36M | $19.55M |
| -应付账款 | $16.35M | $13.75M | $18.36M | $18.36M | $19.55M |
| 一年内应计费用 | $19.90M | $14.61M | $18.20M | $18.20M | $17.62M |
| 短期债务及融资租赁负债 | $19.23M | – | $18.39M | $18.39M | $17.99M |
| -一年内到期融资租赁负债 | $19.23M | $18.81M | $18.39M | $18.39M | $17.99M |
| 非流动负债合计 | $12.19M | $17.03M | $21.91M | $21.91M | $26.62M |
| 长期债务及融资租赁负债 | $11.95M | $16.94M | $21.82M | $21.82M | $26.53M |
| -长期融资租赁负债 | $11.95M | $16.94M | $21.82M | $21.82M | $26.53M |
| 其他非流动负债 | $240,000.00 | $17.03M | $90,000.00 | $90,000.00 | $90,000.00 |
| 股东权益合计 | $1.03B | $1.11B | $1.19B | $1.19B | $1.28B |
| 股东权益 | $1.03B | $2.43B | $1.19B | $1.19B | $1.28B |
| 股本 | $76,000.00 | $0.00 | $75,000.00 | $75,000.00 | $74,000.00 |
| -普通股 | $76,000.00 | – | $75,000.00 | $75,000.00 | $74,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $2.59B | $2.57B | $2.56B | $2.56B | $2.54B |
| 留存收益 | -$761.52M | -$802.49M | -$561.71M | -$561.71M | -$453.67M |
| 减：库存股 | $802.49M | $660.82M | $802.49M | $802.49M | $802.49M |
| 不影响留存收益的损益 | -$1.80M | – | $2.19M | $2.19M | $2.05M |
| -累计折旧 | – | – | -$60.12M | -$60.12M | – |
| -应付税款合计 | – | – | $0.00 | $0.00 | $0.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$57.31M | -$118.92M | -$372.98M | -$96.21M | -$88.15M |
| 持续经营经营活动现金流净额 | -$57.31M | -$118.92M | -$372.98M | -$96.21M | -$88.15M |
| 持续经营净利润 | -$100.70M | -$99.11M | -$412.78M | -$108.04M | -$103.43M |
| 持续经营损益 | -$67,000.00 | -$28,000.00 | -$113,000.00 | -$417,000.00 | $301,000.00 |
| 折旧、折耗与摊销 | $1.35M | $1.36M | $5.18M | $1.27M | $1.37M |
| 其他非现金项目 | $28.32M | $3.26M | $22.43M | $3.20M | $3.14M |
| 营运资金变动 | -$1.03M | -$38.80M | -$33.04M | -$4.59M | -$231,000.00 |
| -应收款变动 | -$8.08M | -$5.56M | -$6.47M | -$5.55M | -$43,000.00 |
| -存货变动 | $4.94M | -$2.17M | -$5.30M | -$886,000.00 | -$1.19M |
| -预付资产变动 | -$4.89M | -$2.46M | -$3.17M | -$945,000.00 | $1.52M |
| -应付账款及应计费用变动 | $11.43M | -$24.16M | -$527,000.00 | $7.10M | $3.74M |
| -其他流动负债变动 | -$4.42M | -$4.46M | -$17.57M | -$4.31M | -$4.26M |
| 投资活动现金流净额 | $40.21M | $141.31M | $377.18M | $90.08M | $95.56M |
| 持续经营投资活动现金流净额 | $40.21M | $141.31M | $377.18M | $90.08M | $95.56M |
| 固定资产购置及出售净额 | -$1.21M | -$769,000.00 | -$4.32M | -$1.12M | -$1.56M |
| 投资购置及出售净额 | $66.42M | $142.08M | $391.50M | $91.20M | $97.11M |
| 筹资活动现金流 | $3.15M | $2.08M | $8.68M | $2.56M | $4.44M |
| 持续经营筹资活动现金流净额 | $3.15M | $2.08M | $8.68M | $2.56M | $4.44M |
| 股票期权行使所得 | $3.15M | $2.08M | $8.68M | $2.56M | $4.44M |
| 期末现金余额 | $99.65M | $113.60M | $89.13M | $89.13M | $92.71M |
| 现金净变动 | -$13.95M | $24.47M | $12.88M | -$3.58M | $11.84M |
| 期初现金余额 | $113.60M | $89.13M | $76.25M | $92.71M | $80.87M |
| 自由现金流 | -$83.52M | -$119.69M | -$387.29M | -$97.33M | -$89.71M |
| 无形资产购置及出售净额 | – | – | -$10.00M | $0.00 | $0.00 |
| 业务购买及出售净额 | – | – | $0.00 | $0.00 | – |
暂无评论——快来第一个聊聊 AGIO。
登录后参与讨论。